Could an arthritis drug ease depression in certain patients?
NCT ID NCT05415397
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 34 times
Summary
This study tests whether adding the anti-inflammatory drug celecoxib to standard depression treatment helps people with a specific type of depression linked to inflammation and energy-related symptoms like fatigue and weight gain. About 140 adults with this depression subtype will receive either celecoxib or a placebo for 12 weeks. The goal is to see if targeting inflammation improves depressive symptoms more than usual care alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Psychiatry Amsterdam UMC
Amsterdam, 1081 HJ, Netherlands
Conditions
Explore the condition pages connected to this study.